International Conference on
ACUTE MYELOID LEUKEMIA: “Molecular and translational” –
Advances in the Biology and Treatment
September 10-12, 2015 – Budapest, Hungary
Chairs: B. Löwenberg, H. Döhner, M. Tallman
Molecular techniques are creating novel insights into the biology and therapeutic perspectives of AML. Molecular diagnosis allows us to distinguish distinct disease entities and to identify patients with different disease behavior and prognosis. Genomic and epigenetic studies have revealed entirely novel insights into the biology of AML, expanded the genomic landscape in unprecedented depth and discovered functional clues of dysregulation. Thus, these studies have profoundly enhanced our understanding of the pathobiology of the disease and identified major pathways of malignant transformation. These insights also furnish keys to the development of novel specifically acting therapeutic drugs and provide the opportunity to develop more sophisticated risk-adjusted therapeutic approaches.
This Conference on ACUTE MYELOID LEUKEMIA intends to promote informal interaction and ample discussion between scientists and clinicians working in the field. Scientific presentations by international leaders will provide the current status and a perspective of these exciting developments. In separate sessions results from both basic and clinical research will be presented. The target audience will comprise besides key opinion leader scientists, PhD students, basic scientists, physician-scientists, as well as clinicians with an interest in the field.
The program will include:
This meeting will be valuable or you if you are looking for:
The deadline to submit an abstract has been reached.
TO BOOK YOUR ACCOMMODATION, PLEASE CONTACT:
ESH local conference secretariat
c/o Forum d’Ideias, Lda.
Rua da Juventude Azeitonense, Lote 137B
2925-588 V.N. Azeitão / Portugal
Tel: +351 21 218 93 93
Fax: +351 21 218 93 92
Apáczai Csere János utca 4,